Literature DB >> 1997927

Uterine papillary serous carcinoma: a review.

C J Dunton1, G Balsara, M McFarland, E Hernandez.   

Abstract

Uterine papillary serous carcinoma, a histologic subtype of endometrial cancer, is characterized by a propensity for deep myometrial invasion, upper abdominal spread, and poor prognosis. We reviewed its histologic and clinical characteristics and compared them to those of endometrial adenocarcinoma with papillary features.

Entities:  

Mesh：

Year:  1991        PMID： 1997927     DOI： 10.1097/00006254-199102000-00014

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN： 0029-7828            Impact factor:   2.347


  5 in total

1.  Factors associated with Type I and Type II endometrial cancer.

Authors:  Ashley S Felix; Joel L Weissfeld; Roslyn A Stone; Robert Bowser; Mamatha Chivukula; Robert P Edwards; Faina Linkov
Journal:  Cancer Causes Control       Date:  2010-07-14       Impact factor: 2.506

2.  Diffusion-weighted imaging in the assessment of tumour grade in endometrial cancer.

Authors:  N Bharwani; M E Miquel; A Sahdev; P Narayanan; G Malietzis; R H Reznek; A G Rockall
Journal:  Br J Radiol       Date:  2011-09-06       Impact factor: 3.039

Review 3.  Promising novel therapies for the treatment of endometrial cancer.

Authors:  Paola A Gehrig; Victoria L Bae-Jump
Journal:  Gynecol Oncol       Date:  2009-11-10       Impact factor: 5.482

4.  Management of women with surgically staged 1 uterine papillary serous cancer.

Authors:  Laurie Elit; Andre Laroche; Lauren Smith; John Mazurka; Francois Moens; Jan Hauspy; Waldo Jimenez
Journal:  ISRN Obstet Gynecol       Date:  2011-09-11

5.  Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT).

Authors:  Nathalie Arians; Robert Foerster; Joachim Rom; Matthias Uhl; Falk Roeder; Jürgen Debus; Katja Lindel
Journal:  Radiat Oncol       Date:  2016-03-18       Impact factor: 3.481
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.